CWK vs IDXX · P/E 39, rev $5.30B vs P/E 40, rev $2.36B
Cushman & Wakefield plc (CWK) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Cushman & Wakefield plc (CWK) is a real estate services company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CWK revenue for 2026-06-30 was $5.30B. Net income was $40.1M. CWK currently screens at market cap $2.91B and trailing P/E 38.9.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CWK currently screens at market cap $2.91B and trailing P/E 38.9. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CWK and IDXX stock pages for the full models.
Not investment advice.